IDTechEx 2022-33 AM Report

Article

Industry set to surpass $41 Billion by 2033

The 3D printing technologies industry is taking a more critical examination of the value that additive manufacturing brings to businesses and supply chains. IDTechEx forecasts that 3D printing will surpass $41 billion by 2033.

In examining thirty individual 3D printing technologies and five major material categories, IDTechEx finds a continuous theme between these important aspects of the industry: expansion.

Evolution of Market Shares for 3D Printing Technologies and Materials 2022-2033. The IDTechEx report includes eighty 10-year forecast lines. Source: IDTechEx – “3D Printing and Additive Manufacturing 2023-2033: Technology and Market Outlook”

Evolution of Market Shares for 3D Printing Technologies and Materials 2022-2033. The IDTechEx report includes eighty 10-year forecast lines. Source: IDTechEx – “3D Printing and Additive Manufacturing 2023-2033: Technology and Market Outlook”

3D printing hardware: expanding through new technologies and players

New entrants with their own unique innovations on 3D printing are popping up every year. New technologies, which span polymer, metal, electronics, ceramics, construction, and composite 3D printing, offer different advantages and disadvantages to incumbents. Parallel to these new technologies are more incremental improvements in established processes.

The broader 3D printing ecosystem: materials, software, post-processing, and services

Taking place in tandem with the expansion and improvement of the 3D printing hardware portfolio is the growth of the broader 3D printing ecosystem, including materials, post-processing, software, and services. In addition, the software, scanners, and services sector of 3D printing is introducing new offerings to simplify the adoption of additive manufacturing by end-users.

Excepted from IDTechEx’s report, “3D Printing and Additive Manufacturing 2023-2033: Technology and Market Outlook”, available at www.IDTechEx.com/3DP

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.